Big Pharma's Covid Exposure

Update: 2020-10-28

Description

Has Big Pharma exposed society to undue risk in the covid era? In our 2nd episode on this issue, Tahir Amin (i-mak.org) takes us through the R & D ecosystem of pharmaceutical development. Is Big Pharma's role to develop life saving products or digest competition? Listeners will understand why this market is in urgent need of a major overhaul. As always, policy pathways are provided as a matter of courtesy. Show notes

Comments

In Channel

On A Win

2021-11-2433:55

600 Ways to Tell a Story

2021-10-2730:33

Tyson Yunkaporta: Phase Shifting Personal Development into Structural Reform

2021-09-2251:59

Life on an 18.6 year cycle

2021-08-2529:09

The $20 Trillion Question

2021-07-2828:57

Rights to the Golden Pen Tick

2021-05-2628:03

Slowing the Economy by De-Speculation

2021-04-2829:44

The Resilience of Extractive Diplomacy

2021-03-2429:18

The Taxation of Big Tech

2021-02-2429:36

We Are Rent

2021-01-2733:50

From Precarity to Self-Preservation

2020-11-2530:05

Big Pharma's Covid Exposure

2020-10-2830:10

The Planning Blame Game Diversion

2020-09-2332:04

The Miracle of the Rentenmark

2020-08-2639:03

Reform Theatre and the Global Housing Crisis

2020-07-2230:22

Big Pharma Plays the Pandemic

2020-06-2432:54

Monopoly Interests in the Pandemic

2020-05-2729:18

Our Dividend Awaits

2020-04-2229:25

Gauging The Green New Deal

2020-02-2629:55

Life After Interest Rates with Josh Ryan-Collins

2020-01-2236:18

00:00

Big Pharma's Covid Exposure

Karl Fitzgerald with Tahir Amin

#box-pro-ellipsis-176725645343748{-webkit-line-clamp:2;}Big Pharma's Covid Exposure

Big Pharma's Covid Exposure

Karl Fitzgerald with Tahir Amin

Big Pharma's Covid Exposure